Videos

Circadian Technologies (Opthea)

By Tom Salemi | November 24, 2015

Participant: Megan Baldwin Dr. Megan Baldwin is CEO/Managing Director of Circadian Technologies (Opthea) and has over 19 years of experience in preclinical and clinical development…

Read More

Iconic Therapeutics

By Tom Salemi | November 24, 2015

Participant: William L. Greene, MD Dr. Greene has served as CEO of Iconic Therapeutics since 2014. He brings 20 years of experience as an operating…

Read More

PanOptica

By Tom Salemi | November 24, 2015

Participant: Paul Chaney Paul G. Chaney is Co-Founder, President & CEO of PanOptica Inc., a biopharma company developing PAN-90806, a novel topical anti-VEGF treatment for…

Read More

Gobiquity

By Tom Salemi | November 24, 2015

With only one in five children who have risk factors for amblyopia getting tested, Gobiquity Mobile Health is continuing to develop its smartphone-based early screening…

Read More

Amblyotech

By Tom Salemi | November 24, 2015

Amblyotech CEO Joseph Koziak describes the company as a “hybrid” life science and software company that is refining its tablet-based treatment platform for amblyopia in…

Read More

DigiSight Technologies

By Tom Salemi | November 24, 2015

DigiSight Technologies announced at OIS@AAO 2015 that it was launching its Paxos product suite that combines its mobile vision assessment tool, ophthalmic imaging system and…

Read More

MDbackline

By Tom Salemi | November 24, 2015

MDbackline has developed a cloud-based, secure, online software that automates physician contact with patients outside of the office and can work with any electronic health…

Read More

ALPHAEON

By Tom Salemi | November 24, 2015

In the world of self-pay physician services, connecting patients and providers on a broad scale has been difficult, but with the introduction of its ShoutMD…

Read More

Aerie Pharmaceuticals

By Tom Salemi | November 24, 2015

Rhopressa is a Rho-kinase inhibitor that increases the outflow of the trabecular meshwork by relaxing it. It’s also a norepinephrine transport inhibitor that decreases the…

Read More

Ophthotech Corporation

By Tom Salemi | November 24, 2015

Fovista is an anti-platelet derived growth factor (PDGF) agent for wet age-related macular degeneration (AMD) combination therapy currently in phase 3 studies. Pending regulatory approval,…

Read More

Spark Therapeutics

By Tom Salemi | November 24, 2015

Spark was founded about 2 years ago with the vision of building a fully integrated gene therapy company with research and development, manufacturing, and commercial…

Read More

Second Sight Medical Products

By Tom Salemi | November 24, 2015

The Argus II transmits images wirelessly to a layer of 60 tiny electrodes on the retina inside the eye, to reverse vision lost as a…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.